What is the purpose of this trial?
This randomized phase III trial studies how well nivolumab after surgery and chemotherapy work in treating patients with stage IB-IIIA non-small cell lung cancer. Monoclonal antibodies, such as nivolumab, may stimulate the immune system in different ways and kill tumor cells remaining after surgery and standard of care chemotherapy.
Eastern Cooperative Oncology Group
Start Date: 02/14/2017
End Date: 07/01/2024
Last Updated: 10/09/2018
Study HIC#: 1608018203